FGF21 and metabolic dysfunction-associated steatotic liver disease: Studies have shown that FGF-21 strongly correlates with hepatic triglyceride content and MASLD histologic features, including inflammation and fibrosis.17 This supports our findings, where obese MASLD adolescents exhibited the highest levels, likely due to more significant hepatic lipid accumulation and metabolic stress.